The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo

被引:0
|
作者
Valerie Reinke
Guillermina Lozano
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Molecular Genetics
来源
Oncogene | 1997年 / 15卷
关键词
apoptosis; p53; targets; ionizing radiation; mice;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor p53 can exert its anti-oncogenic activity in part by inducing apoptosis in cells that have sustained damage to their DNA. It is likely that p53 activates the transcription of target genes that mediate this response. Known p53 targets with potential roles in cell cycle control and apoptosis induction include: p21WAF1/CIP1, mdm2, cyclin G, bax and Fas. We examined the p53 pathway in the thymus of the mouse after irradiation. FACS analysis demonstrated that the thymocytes of mice with wild-type p53, but not those lacking p53, underwent apoptosis after irradiation. Expression analysis of the target genes revealed that all tested genes underwent p53-dependent induction, although the extent and timing varied. The target genes implicated in cell cycle (p21, mdm2 and cyclin G) were induced 2 h after irradiation, in contrast to targets with a possible role in apoptosis (bax and Fas), which were induced at 4 h. This analysis is the first demonstration that Fas is a p53-responsive gene in vivo. Since p21 and bax expression are not required for p53-dependent apoptosis, we tested whether other target genes affected apoptosis in vivo. We discovered that mdm2 has no role in preventing apoptosis independently of p53 inactivation, and that Fas, like p21 and bax, is not necessary for p53-mediated induction of apoptosis. Therefore, no p53 target identified and tested to date is singly responsible for p53-dependent apoptosis in response to DNA damage in vivo.
引用
收藏
页码:1527 / 1534
页数:7
相关论文
共 50 条
  • [31] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    NATURE, 1997, 387 (6630) : 299 - 303
  • [32] MDM2: life without p53
    Daujat, S
    Neel, H
    Piette, J
    TRENDS IN GENETICS, 2001, 17 (08) : 459 - 464
  • [33] p53和mdm2基因
    沈行良
    翁启芳
    中国热带医学, 2007, (01) : 103 - 105
  • [34] mdm2/p53与肿瘤
    金永丽
    王靖华
    陈龙邦
    临床肿瘤学杂志, 2007, (06) : 469 - 471
  • [35] Regulation of p53 stability by Mdm2
    Michael H. G. Kubbutat
    Stephen N. Jones
    Karen H. Vousden
    Nature, 1997, 387 : 299 - 303
  • [36] Mdm2: p53's lifesaver?
    Shmueli, Ayelet
    Oren, Moshe
    MOLECULAR CELL, 2007, 25 (06) : 794 - 796
  • [37] Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells
    Kao, Chia-Li
    Hsu, Han-Shui
    Chen, Hsin-Wu
    Cheng, Tzu-Hao
    CANCER LETTERS, 2009, 286 (02) : 250 - 259
  • [38] The p53 mRNA-Mdm2 Interaction Controls Mdm2 Nuclear Trafficking and Is Required for p53 Activation following DNA Damage
    Gajjar, Madhavsai
    Candeias, Marco M.
    Malbert-Colas, Laurence
    Mazars, Anne
    Fujita, Jun
    Olivares-Illana, Vanesa
    Fahraeus, Robin
    CANCER CELL, 2012, 21 (01) : 25 - 35
  • [39] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [40] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000